Abstract: A series of novel chiral 5-(substituted aryl)-1,3,4-thiadiazole derivatives was synthesized in an enantioselective three-component Mannich reaction using cinchona alkaloid squaramide catalyst with excellent enantioselectivities (up to >99% enantiomeric excess (ee)). The bioassay results showed that these derivatives possessed good to excellent activities against tobacco mosaic virus (TMV).
Introduction
The design and synthesis of novel compounds that have value as agricultural therapeutic agents is one of the fundamental objectives of organic chemistry. During the past two decades, the number of non-racemic pesticides on the agrochemical market has been consistently increasing. Many novel non-racemic agrochemicals have desirable biological activity and can be used in smaller quantities because they possess low mammalian toxicity and environmental friendliness [1] [2] [3] . For example, metolachlor is a herbicide that was first used as a racemate.
The (R)-enantiomer is inactive, and modern production methods afford only (S)-metolachlor [4] .
Due to their proven utility in medicinal chemistry, there has been greater interest in heterocyclic compounds [5] [6] . There are a large number of biologically active organic compounds with five-membered rings containing three heteroatoms. The 1,3,4-thiadiazole heterocycle is the most widely existing one. A survey of the available literature shows that the 1,3,4-thiadiazole heterocycle is a key structure associated with many bioactive molecules [7] [8] [9] . For example, several biologically active molecules with a 1,3,4-thiadiazole moiety are known to exhibit significant insecticidal [10] , antifungal [11] , and antiviral activity against TMV properties [12] . However, research on modified 1,3,4-thiadiazole derivatives has mainly focused on racemic ones. Only one work has been reported using 1,3,4-thiadiazole as a substrate in an asymmetric reaction, a study by Hu's group. They gave the corresponding products with moderate yields (37-53%) and enantioselectivities (43-91%) [13] . In addition, our group has previously described the asymmetric addition of malonate with benzothiazolyl imine [14] , and it was proven that the thiourea-cinchonine alkaloid derivatives were highly efficient catalysts in the synthesis of chiral β-amino esters bearing a benzothiazole moiety. Based on our technical competence in the field of plant virology, to exploit novel high-efficiency chiral anti-plant-virus agents, we decided to apply the cinchona alkaloid catalyst to synthesis of masked chiral 5-(substituted aryl)-1,3,4-thiadiazole derivatives. Additionally, the antiviral activity of chiral products against TMV from our asymmetric reaction was tested.
Results and Discussion
For optimization of the experimental conditions, we initially employed commercial quinine and cinchona alkaloid derivatives Q-1-Q-5 ( Figure 1 ) in a one-pot asymmetric catalytic Mannich reaction of 5-phenyl-1,3,4-thiadiazol-2-amine, benzaldehyde, and dimethyl malonate (entry 1-6, Table 1 ). Quinine was a poor catalyst, whereas cinchona alkaloid-squaramide catalyst Q-5 afforded an especially promising result at 30°C for 60 h (entry 6, Table 1 ). Next, the influence of solvents on the model reaction was studied using the optimal catalyst Q-5 (entries 6-9, Table 1 ). Toluene showed higher enantioselectivity than alternative solvents. Four gradients (40 °C, 50 °C, 60 °C, and 70 °C) of reaction temperature were evaluated in this reaction (entries 10-13, Table 1 ). It was determined that 60 °C was suitable for obtaining high yield and excellent enantioselectivity (entry 12, Table 1 ). The best results were achieved at 60°C with 10 mol% catalyst loading in toluene.
Having established the optimal reaction conditions, the substrate generality of this asymmetric Mannich reaction was investigated, and the results are summarized in Table 2 . In all cases, the Mannich reaction proceed smoothly when catalyst Q-5 was used, giving the desired chiral 5-(substituted aryl)-1,3,4-thiadiazole derivatives in high isolated yields (71-90%) and excellent enantiomeric excess (up to 99% ee). Significantly, both dimethyl malonate (entries 1-3, Table 2 ) and diethyl malonate (entries 4-8, Table 2 ) proved to be good substrates with a high yield and ee values. It should be noted that the different configurations were observable using Q-5 as the catalyst.
The anti-TMV activity of the synthesized chiral compounds was tested using previously reported method [15] . As shown in Table 3 . Most chiral compounds exhibited moderate to good antiviral activity against TMV in vivo, and some of them even exhibited higher antiviral activity than the commercially available plant antiviral agent ribavirin.
Conclusions
We developed an efficient one-pot three-component selective catalytic method for the synthesis of masked chiral 5-(substituted aryl)-1,3,4-thiadiazole derivatives using chiral cinchona alkaloid-squaramide catalyst in good yields with excellent enantioselectivities (up to 99% ee). Several new chiral derivatives from our reaction showed potential anti-plant virus activities against TMV.
Experimental
IR spectra were recorded on a Bruker Vector 22 spectrometer. NMR spectra were recorded at 500 MHz ( 1 H) and 125 MHz ( 13 H) on a JEOL-ECX 500 NMR spectrometer using TMS as an internal standard and DMSO-d 6 or CDCl 3 as a solvent. Mass spectral studies were conducted on an Agilent 5973 organic mass spectrometer. Elemental analysis was performed on an Elementar Vario-III CHN analyzer. High-performance liquid chromatography (HPLC) analysis was performed on an Agilent 1100/1200 Series system using a Daicel Chiralcel IA Column (250 mm × 4.6 mm). HPLC analysis: Hexane/IPA = 70/30, 1.0 mL⋅min -1 . Analytical TLC was performed on silica gel GF254. Except where otherwise stated, all reagents were purchased from Aladdin-reagent Inc. and Sigma-Aldrich Inc., and all the commercial reagents were used as received.
General experimental procedure to prepare 4a-4h: Diethyl malonate or dimethyl malonate (1.20 mmol) in toluene (2.0 mL) was added all at once to a mixture of 5-(substituted aryl)-1,3,4-thiadiazole-2-amine (1.0 mmol), aldehyde (1.0 mmol), and chiral catalyst Q-5 (10 mol%) at 60 °C and stirred for 60-72 h. After completion of the reaction, the reaction mixture was directly purified by preparative TLC hexane/ethyl ether = 3/1 afforded the desired compounds 4a-4h. 5-phenyl-1,3 (3-fluoro  phenyl)-1,3,4-thiadiazol-2-yl) 
(+)-Dimethyl 2-(phenyl((

